| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/18/1996 | US5527700 Target antigens of transmission blocking antibodies for malaria parasites |
| 06/18/1996 | US5527692 Comprising activated recombinant gla-domainless prothrombin, which is cleavable to thrombin |
| 06/18/1996 | US5527691 Expression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/18/1996 | US5527690 Methods and compositions relating to sterol regulatory element binding proteins |
| 06/18/1996 | US5527685 Monoclonal or polyclonal antibodies |
| 06/18/1996 | US5527682 Purified polypeptide products and their mutants and variants in mammalian cells |
| 06/18/1996 | US5527679 β5 protein and DNA encoding the same |
| 06/18/1996 | US5527678 CagB and CagC genes of helicobacter pylori and related compositions |
| 06/18/1996 | US5527675 Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| 06/18/1996 | US5527674 Genetic construct for selection of homologous recombinants on a single selective medium |
| 06/18/1996 | US5527669 Oligonucleotide primers used to amplify and detect virus via reverse transcription |
| 06/18/1996 | US5527668 Stable DNA constructs |
| 06/18/1996 | US5527666 Method for the diagnosis in vitro of HIV-1 virus infections |
| 06/18/1996 | US5527610 Comprising tetrapeptide or pentapeptide repeating units containing proline and glycine with optional alanine residues |
| 06/18/1996 | US5527555 Isolated from pentadiplandra brazzeana baillon |
| 06/18/1996 | US5527546 Human interleukin 6 inhibitor |
| 06/18/1996 | US5527527 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
| 06/18/1996 | CA2064754C Method of preparing polypeptides in a cell-free translation system |
| 06/18/1996 | CA2064685C Method of preparing polypeptides in a cell-free translation system |
| 06/18/1996 | CA1338401C Anticoagulant polypeptide |
| 06/13/1996 | WO1996018105A1 Single chain t-cell receptor |
| 06/13/1996 | WO1996018104A1 Melittin-related polypeptides, mixture sets and libraries thereof |
| 06/13/1996 | WO1996018103A1 Inhibition of glial cell proliferation |
| 06/13/1996 | WO1996017960A2 Methods for inhibiting the transcription-enhancing activity of the x protein of hepatitis b virus |
| 06/13/1996 | WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms |
| 06/13/1996 | WO1996017947A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 06/13/1996 | WO1996017945A1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/13/1996 | WO1996017943A1 A process of producing extracellular proteins in bacteria |
| 06/13/1996 | WO1996017942A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | WO1996017941A2 Production of c-terminal amidated peptides from recombinant protein constructs |
| 06/13/1996 | WO1996017939A1 Isolated herpesvirus saimiri proteins that bind mhc class ii molecules |
| 06/13/1996 | WO1996017938A1 Glycoproteins from herpes virus and vaccines containing them |
| 06/13/1996 | WO1996017937A2 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 06/13/1996 | WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 06/13/1996 | WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | WO1996017934A2 Cloning and recombinant production of crf receptor(s) |
| 06/13/1996 | WO1996017933A2 Dna encoding a cell growth inhibiting factor and its product |
| 06/13/1996 | WO1996017931A1 Human vascular ibp-like growth factor |
| 06/13/1996 | WO1996017927A2 Reporter cell line |
| 06/13/1996 | WO1996017926A1 Transgenic animal lacking native amyloid precursor protein |
| 06/13/1996 | WO1996017925A1 Cytokine designated lerk-7 |
| 06/13/1996 | WO1996017924A2 Novel hedgehog-derived polypeptides |
| 06/13/1996 | WO1996017873A1 Diagnosis of pancreatitis |
| 06/13/1996 | WO1996017872A1 Intermediate for producing surfactant peptide |
| 06/13/1996 | WO1996017871A1 Plasma concentrate and tissue sealant compositions |
| 06/13/1996 | WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 06/13/1996 | WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | WO1996017867A1 Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use |
| 06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 06/13/1996 | WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | WO1996017864A1 A 12-kda protein derived from m. tuberculosis useful for treatment of autoimmune diseases |
| 06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/13/1996 | WO1996017631A1 Heat treated blood plasma proteins |
| 06/13/1996 | WO1996017627A2 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 06/13/1996 | WO1996017617A1 Neuromedin b receptor antagonists |
| 06/13/1996 | WO1995034670A3 Recombinant aav genome encoding immunodeficiency virus protein |
| 06/13/1996 | DE19512346C1 Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin A process for the purification of pertussis toxin and Filamenthämagglutinin |
| 06/13/1996 | DE19502525A1 Neue Gene und Genprodukte zur Diagnostik und Regeneration degenerativer Nervenschädigungen New genes and gene products for diagnosis and regeneration of degenerative nerve damage |
| 06/13/1996 | CA2208139A1 Methods for inhibiting the transcription-enhancing activity of the x protein of hepatitis b virus |
| 06/13/1996 | CA2208052A1 Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use |
| 06/13/1996 | CA2207927A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 06/13/1996 | CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | CA2207216A1 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 06/13/1996 | CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | CA2206848A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | CA2206789A1 Transgenic animal lacking native amyloid precursor protein |
| 06/13/1996 | CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 06/13/1996 | CA2206640A1 Human vascular ibp-like growth factor |
| 06/13/1996 | CA2206488A1 Cytokine designated lerk-7 |
| 06/13/1996 | CA2206321A1 Inhibition of glial cell proliferation |
| 06/13/1996 | CA2205663A1 Neuromedin b receptor antagonists |
| 06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/12/1996 | EP0716150A1 DNA primer and a method for screening DNAs |
| 06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
| 06/12/1996 | EP0716146A2 A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein |
| 06/12/1996 | EP0716145A1 Improved steroid hormone superfamily receptors, and their use in screening and identifying potential antagonists |
| 06/12/1996 | EP0716094A1 Process for purifying hepatitis B viral surface antigen comprising preS2 peptide |
| 06/12/1996 | EP0715721A1 Phosphate assay |
| 06/12/1996 | EP0715633A1 Haemopoietic growth factor antagonists |
| 06/12/1996 | EP0715521A1 Method of inhibiting kaposi's sarcoma |
| 06/12/1996 | EP0590044A4 Composition and treatment with biologically active peptides having c-terminal substitutions |
| 06/12/1996 | EP0573552B1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 06/12/1996 | EP0538353B1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 06/12/1996 | EP0537318B1 New non-hygroscopic mono-ammonium salts |
| 06/12/1996 | EP0463151B1 Generation of xenogeneic antibodies |
| 06/12/1996 | EP0437610B1 Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide |
| 06/12/1996 | EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity |
| 06/12/1996 | EP0414915B1 New superoxide dismutase |
| 06/12/1996 | EP0373192B1 Diagnostic genes for toxoplasmosis |
| 06/12/1996 | EP0293471B1 Primary biliary cirrhosis autoantigen |
| 06/12/1996 | CN1124502A Mammal cell lines and method of obtaining glycoproteins |
| 06/12/1996 | CN1124491A Inhibitor of stem cell proliferation and uses thereof |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
| 06/11/1996 | US5525727 Brain-specific drug delivery |
| 06/11/1996 | US5525716 Polynucleotides for genetic engineering propagation |